| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 9, Issue 1 1-11, Copyright © 1998 by American Association of Cancer Research
ARTICLES |
SD Zabludoff, M Csete, R Wagner, X Yu and BJ Wold
Division of Biology, California Institute of Technology, Pasadena 91125, USA.
Vertebrate skeletal muscle development is characterized by tight coupling of muscle differentiation with cell cycle arrest in G1/G0. Key regulators of G1 progression are the G1 cyclin-dependent kinases, their positive regulators, the G1 cyclins, and their negative regulators, the cyclin-dependent kinase inhibitors (CDIs). Here we show that p27Kip1 protein, a G1 CDI, is expressed in a prominent but transient wave in the developing myotomes of the mouse embryo. We relate its expression to expression of MyoD and myogenin proteins, which are determination and differentiation class myogenic regulatory factors, respectively. Functional assays showed that ectopic p27 expression can powerfully enhance the efficiency of MyoD-initiated muscle differentiation in cell culture. When considered together with the myotomal expression patterns of p18, p21, and p57, these results suggest a model in which p27 acts as a "trigger" CDI while myoblasts are exiting the cell cycle and initiating differentiation. At later times, when p27 protein has been down-regulated, it is proposed that accumulation of p18, p21, and p57 maintain the differentiated myocytes in a postmitotic state.
This article has been cited by other articles:
![]() |
D. Pajalunga, A. Mazzola, A. M. Salzano, M. G. Biferi, G. De Luca, and M. Crescenzi Critical requirement for cell cycle inhibitors in sustaining nonproliferative states J. Cell Biol., March 12, 2007; 176(6): 807 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shibutani, L. M. Swanhart, and R. J. Duronio Rbf1-independent termination of E2f1-target gene expression during early Drosophila embryogenesis Development, February 1, 2007; 134(3): 467 - 478. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Saab, J. L. Bills, A. P. Miceli, C. M. Anderson, J. D. Khoury, D. W. Fry, F. Navid, P. J. Houghton, and S. X. Skapek Pharmacologic inhibition of cyclin-dependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cells Mol. Cancer Ther., May 1, 2006; 5(5): 1299 - 1308. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Lees, C. R. Rathbone, and F. W. Booth Age-associated decrease in muscle precursor cell differentiation Am J Physiol Cell Physiol, February 1, 2006; 290(2): C609 - C615. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Messina, C. Blasi, S. A. La Rocca, M. Pompili, A. Calconi, and M. Grossi p27Kip1 Acts Downstream of N-Cadherin-mediated Cell Adhesion to Promote Myogenesis beyond Cell Cycle Regulation Mol. Biol. Cell, March 1, 2005; 16(3): 1469 - 1480. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Di Carlo, R. De Mori, F. Martelli, G. Pompilio, M. C. Capogrossi, and A. Germani Hypoxia Inhibits Myogenic Differentiation through Accelerated MyoD Degradation J. Biol. Chem., April 16, 2004; 279(16): 16332 - 16338. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cao, Z. Zhao, J. Gruszczynska-Biegala, and A. Zolkiewska Role of Metalloprotease Disintegrin ADAM12 in Determination of Quiescent Reserve Cells during Myogenic Differentiation In Vitro Mol. Cell. Biol., October 1, 2003; 23(19): 6725 - 6738. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Vernon and A. Philpott A single cdk inhibitor, p27Xic1, functions beyond cell cycle regulation to promote muscle differentiation in Xenopus Development, January 1, 2003; 130(1): 71 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cossins, A. E. Vernon, Y. Zhang, A. Philpott, and P. H. Jones Hes6 regulates myogenic differentiation Development, January 5, 2002; 129(9): 2195 - 2207. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Goichberg, M Shtutman, A Ben-Ze'ev, and B Geiger Recruitment of (&bgr;)-catenin to cadherin-mediated intercellular adhesions is involved in myogenic induction J. Cell Sci., January 4, 2001; 114(7): 1309 - 1319. [Abstract] [PDF] |
||||
![]() |
C. J. Jones, D. Kipling, M. Morris, P. Hepburn, J. Skinner, A. Bounacer, F. S. Wyllie, M. Ivan, J. Bartek, D. Wynford-Thomas, et al. Evidence for a Telomere-Independent "Clock" Limiting RAS Oncogene-Driven Proliferation of Human Thyroid Epithelial Cells Mol. Cell. Biol., August 1, 2000; 20(15): 5690 - 5699. [Abstract] [Full Text] |
||||
![]() |
T. Taniguchi, H. Endo, N. Chikatsu, K. Uchimaru, S. Asano, T. Fujita, T. Nakahata, and T. Motokura Expression of p21Cip1/Waf1/Sdi1 and p27Kip1 Cyclin-Dependent Kinase Inhibitors During Human Hematopoiesis Blood, June 15, 1999; 93(12): 4167 - 4178. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Y. Chang, L. Birch, C. Woodham, L. I. Gold, and G. S. Prins Neonatal Estrogen Exposure Alters the Transforming Growth Factor-{beta} Signaling System in the Developing Rat Prostate and Blocks the Transient p21cip1/waf1 Expression Associated with Epithelial Differentiation Endocrinology, June 1, 1999; 140(6): 2801 - 2813. [Abstract] [Full Text] |
||||
![]() |
R. V. Lloyd, L. A. Erickson, L. Jin, E. Kulig, X. Qian, J. C. Cheville, and B. W. Scheithauer p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human Cancers Am. J. Pathol., February 1, 1999; 154(2): 313 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Negishi, N. Ui, M. Nakajima, K. Kawashima, K. Maruyama, T. Takizawa, and H. Endo p21Cip-1/SDI-1/WAF-1 Gene Is Involved in Chondrogenic Differentiation of ATDC5 Cells in Vitro J. Biol. Chem., August 24, 2001; 276(35): 33249 - 33256. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. L. de la Serna, K. Roy, K. A. Carlson, and A. N. Imbalzano MyoD Can Induce Cell Cycle Arrest but Not Muscle Differentiation in the Presence of Dominant Negative SWI/SNF Chromatin Remodeling Enzymes J. Biol. Chem., October 26, 2001; 276(44): 41486 - 41491. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |